Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Here's Why Small-Cap ETFs Are Looking Great Buys Now

Published 05/25/2021, 03:56 AM
Updated 07/09/2023, 06:31 AM

Wall Street cheered the welcoming news of declining new coronavirus cases as economic reopening trades kept the optimism levels high. Accordingly, the Dow Jones Industrial Average increased 0.6% on May 24. The S&P 500 rose 1% on the back of strength in the tech and communication services sectors. Moreover, the Nasdaq Composite was also up 1.4% on the same trading day. Major technology players like Alphabet (NASDAQ:GOOGL) GOOGL, Facebook (NASDAQ:FB) FB and Microsoft MSFT increased more than 2% on May 24.

Notably, shares of American Airlines (NASDAQ:AAL) AAL and United Airlines rose at least 1%. Carnival (NYSE:CUK) (CCL) was also up around 2.7%. Norwegian Cruise Line (NYSE:NCLH) increased 4.7% post the announcement of plans to restart cruising in the United States this summer, per a CNBC article.

Markedly, the small-cap centric index, namely the Russell 2000, rose 0.5%. This upside is being largely led by small-cap companies that are closely tied to the U.S. economy and are therefore well-positioned to outshine when the economy improves.

Going by data compiled by Johns Hopkins University, the seven-day average of new infections was about 26,000 as of May 23, per a CNBC article. Encouragingly, the number of cases has dropped to the lowest level since June 2020. Accelerated coronavirus vaccine rollout has been the major factor that has helped gain control over the aggravating outbreak.

President Joe Biden recently announced his latest vaccination goals. He aims at administering at least one dose of a coronavirus vaccine to 70% of U.S. adults along with getting 160 million adults completely vaccinated by Jul 4, per a CNBC article.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Notably, around 39% of the Americans are completely vaccinated as of May 22, per data from the Centers for Disease Control and Prevention (CDC) (as mentioned in a CNBC article). The same article also mentions that around 49% of the U.S. population has received at least one dose of the coronavirus vaccine. Going on, 61% of the Americans are at least partially vaccinated among the age group of 18 years and older, per the CDC data.

Going on, the latest public health guidelines issued by the CDC have relaxed restrictions on wearing masks at indoor and public gatherings. According to the new recommendations, completely vaccinated people do not need to wear masks or stay six feet away from others at indoor or outdoor gatherings, per a CNBC article.

Small-Cap ETFs to Consider

For investors looking to capitalize on this opportunity, the following small-cap ETFs could be strong pure plays:

Vanguard Small-Cap Growth ETF VBK

This fund follows the CRSP US Small Cap Growth Index. The product managed assets worth $14.92 billion, and charges 7 basis points (bps) in annual fees and expenses. The fund currently sports a Zacks ETF Rank #3 (Hold), with a Medium-risk outlook (read: Add These Small-Cap ETFs to Your Portfolio in Q2).

iShares Russell 2000 Growth ETF IWO

This fund tracks the Russell 2000 Growth Index and offers exposure to small-cap companies that have earnings growth expectations above average rate relative to the market. The product managed assets worth $11.32 billion and charges 24 bps in annual fees and expenses. The fund presently flaunts a Zacks ETF Rank of 3, with a High-risk outlook (read: ETFs at Risks If Tax Law Changes in U.S.).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

iShares S&P Small-Cap 600 Growth ETF IJT

This product tracks the S&P SmallCap 600 Growth Index. It managed assets worth $6.17 billion and charges 18 bps in annual fees and expenses. The fund carries a Zacks ETF Rank #2 (Buy), with a Medium-risk outlook.

SPDR S&P 600 SmallCap Growth ETF SLYG

This ETF follows The S&P SmallCap 600 Growth Index, which comprises stocks that exhibit the strongest growth characteristics based on sales growth, earnings change to price and momentum. The product managed assets worth $2.18 billion and charges 15 bps in annual fees and expenses. The fund carries a Zacks ETF Rank #2, with a Medium-risk outlook.

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Microsoft Corporation (NASDAQ:MSFT): Free Stock Analysis Report

American Airlines Group Inc. (AAL): Free Stock Analysis Report

Facebook, Inc. (FB): Free Stock Analysis Report

Alphabet Inc. (GOOGL): Free Stock Analysis Report

ISHARS-RS 2K GR (IWO): ETF Research Reports

ISHARS-SP SC GR (IJT): ETF Research Reports

VIPERS-SC GRWTH (VBK): ETF Research Reports

SPDR-SP6 SC GR (SLYG): ETF Research Reports

To read this article on Zacks.com click here.

Zacks Investment Research

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Good read
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.